共 50 条
- [3] A pooled analysis of two phase 3 trials assessing the percentage of days linaclotide improved abdominal symptoms and stool frequency in patients with IBS-C NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 107 - 108
- [4] Improvement in abdominal symptoms rated as most severe by patients with Irritable Bowel Syndrome with Constipation (IBS-C): Results from two phase 3 trials of linaclotide NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 27 - 27
- [7] A pooled analysis of two phase 3 trials to determine the effects of linaclotide treatment on patient-reported ratings of change for symptoms of Irritable Bowel Syndrome with Constipation (IBS-C) NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 105 - 106
- [9] Effects of linaclotide on abdominal and bowel symptoms over the first seven days of treatment in patients with Irritable Bowel Syndrome (IBS) with constipation NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 105 - 105
- [10] Bloating is more strongly associated with abdominal pain than with stool frequency in irritable bowel syndrome with constipation (IBS-C) AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S343 - S343